A randomized, multicenter phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Moiseev I, Drokov M, Kitaeva Yu, Tatyana Rudakova, M. V. Barabanshikova, Daria Chernyshova, Sergey Bondarenko, Larisa Kuzmina, Gennady Rodionov, Ekaterina Svetkina, Sergey Lapin, И. В. Холопова
+7 more Elena Morozova, Vera Vasilyeva, Yu. Yu. Vlasova, Dmitrii Zhogolev, Konstantinova T, Elena Parovichnikova, Kulagin A
DOI: 10.1016/j.jtct.2026.04.042
Cited by: 3
References: 52

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation CAR-T cell therapy research Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Volume
32
Issue
9
Pages
1117.e1–1117.e11
Publication date
1 May 2026
Language
EN